Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ
Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
Department of Biostatistics, Mayo Clinic, Scottsdale, AZ
Department of Biostatistics, Mayo Clinic, Scottsdale, AZ
Department of Medical Oncology, Mayo Clinic, Rochester, MN
Department of Medical Oncology, Mayo Clinic, Rochester, MN
Department of Radiology, Mayo Clinic, Rochester, MN
Department of Medical Oncology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Haematologica Early view Apr 3, 2025 https://doi.org/10.3324/haematol.2024.286808

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2024.286808
Pubmed
40176753
 
Published
2025-04-03
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
312
PDF Downloads
143

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online